GT Biopharma Statistics
NASDAQ: GTBPHealth CareBiotechnology: Pharmaceutical PreparationsUSD
6.30+0.35 (+5.88%)
Market open · Delayed 15 min · as of Oct 9, 12:29 PM ET
GT Biopharma by the numbers
GT Biopharma has a market capitalization of $11.4 million based on 1.80M shares outstanding. With trailing EPS of $-147.50, GT Biopharma is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 12.7% below its 50-day average and 41.7% below its 200-day average.
Average daily trading volume is 55.52K shares, or about $349,763 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
GTBP valuation vs. peer median
| Metric | GTBP | Peer median | Difference |
|---|---|---|---|
| Market cap | $11.37M | $10.61M | +7% |
| Avg. volume | 55.52K | 96.01K | -42% |
Peer median across 8 companies: CMMB, VTGN, ADIL, GDTC, BLRX, ENSC, TOVX, KPRX.
Valuation
- Market cap
- $11.37M
- EPS (TTM)
- $-147.50
- Shares outstanding
- 1.80M
Price and trading
- Previous close
- 5.95
- Open
- 5.96
- Day range
- 5.87 – 6.31
- 52-week range
- 4.91 – 28.75
- 52-week change
- +451.85%
- Beta
- —
- Volume
- 13.69K
- Average volume
- 55.52K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Aug 12, 2025
Additional statistics
- Market Cap
- 11.37M
- Forward Pe
- -0.58
- Eps
- -147.50
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 28.75
- Week52 Low
- 4.91
- Avg Volume
- 55,518.00
- Shares Outstanding
- 1.80M
- Ma50
- 7.21
- Ma200
- 10.80
- Earnings Date
- Aug 12, 2025
- Pct From52w High
- -78.09%
- Pct From52w Low
- 28.31%